Recurrent Metastatic Nasopharyngeal Carcinoma
1 clinical trials · Condition
◉ Watch Recurrent Metastatic Nasopharyngeal Carcinoma
| Record | Firm | Date |
|---|---|---|
| Clinical Study of Mitoxantrone Hydrochloride Liposome Injection Combined With Capecitabine Versus Capecitabine Monotherapy in Patients With Recurrent Metastatic Nasopharyngeal Carcinoma Who Failed Platinum-containing Treatment (NCT05717764) | CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. | 2023-02-01 |
Track Recurrent Metastatic Nasopharyngeal Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.